The sexually transmitted pathogen Neisseria gonorrhoeae is regarded as being on the way to becoming an untreatable superbug. Despite its clinical importance, little is known about its emergence and evolution, and how this corresponds with the introduction of antimicrobials. We present a genome-based phylogeographical analysis of 419 gonococcal isolates from across the globe. Results indicate that modern gonococci originated in Europe or Africa, possibly as late as the sixteenth century and subsequently disseminated globally. We provide evidence that the modern gonococcal population has been shaped by antimicrobial treatment of sexually transmitted infections as well as other infections, leading to the emergence of two major lineages with different evolutionary strategies. The well-described multidrug-resistant lineage is associated with high rates of homologous recombination and infection in high-risk sexual networks. A second, multisusceptible lineage is more associated with heterosexual networks, with potential implications for infection control.
A lmost 360 million curable sexually transmitted infections (STIs) are estimated to occur globally each year, with Neisseria gonorrhoeae, the causative agent of gonorrhoea, infecting approximately 78 million 1 . The highest gonorrhoea burden is reported among men, although problematic infections are more common in women for whom urogenital infections are often asymptomatic. Unresolved urogenital infections can lead to severe complications and sequelae, such as reproductive problems including infertility, serious eye infections in newborn babies and enhanced transmission of HIV 2 . The emergence and proliferation of gonococci with resistance to front-line antimicrobials, such as extended-spectrum cephalosporins (cefixime and ceftriaxone) and azithromycin, have contributed to, although do not explain, the increase in incidence of gonorrhoea. Resistance to dual therapy (injectable ceftriaxone plus oral azithromycin), the current recommended treatment in many countries, is fortunately rare 3 ; however, decreased susceptibility to ceftriaxone has been reported from all continents and azithromycin resistance is on the increase globally 4 , raising fears that the effectiveness of this regimen will be short-lived. Much of the focus of gonococcal control is on particular high-risk sexual networks that often partake in unprotected sex with multiple partners, particularly sex workers and men who have sex with men but also young heterosexuals. These groups are more frequently exposed to both infection and antimicrobial treatment, which has led to these networks being the suspected drivers of antimicrobial resistance (AMR) 5 . However, AMR is not the only factor driving the recent success of N. gonorrhoeae. Dual therapy is effective against the vast majority of infections, yet since its introduction, gonorrhoea infections have continued to increase in most settings 6 .
Georges Luys famously opened his medical textbook on gonorrhoea with the statement that "Gonorrhoea is as old as mankind" 7 .
However, despite N. gonorrhoeae often being described as an ancient pathogen, there are no clear descriptions of a disease like modern gonorrhoea in the ancient sources. Some compatible symptoms do appear in the medical literature of classical Greece and Rome, but nothing decisive, and the presence or absence of modern gonorrhoea in the ancient Mediterranean has been much debated as a result 8 . Early modern terms such as 'the clap' , 'the pox' or 'the venereal disease' also covered a range of conditions, and it was not until 1879 that Albert Neisser identified the bacteria that now bears his name 9 . AMR in N. gonorrhoeae became apparent soon after antimicrobials were first introduced for its treatment. One characteristic of N. gonorrhoeae that has played an important role in its rapid gain and spread of AMR is its ability to exchange DNA via homologous recombination both within its own species and with other Neisseria species. For example, mosaic penA (encoding penicillin-binding protein 2 (PBP2)) alleles gained via recombination have been key in the emergence of resistance to extended-spectrum cephalosporins 10, 11 , which led to the replacement of cefixime as the first-line treatment for gonorrhoea. The first mosaic penA allele that caused high-level ceftriaxone resistance was seen in an isolate from a pharyngeal infection in a female sex worker in Japan in 2009 (ref. 12 ), but similar mosaic penA alleles have been seen worldwide 2, 11, 13, 14 . In fact, a number of resistances were first identified in Japan, leading to the hypothesis that most AMR gonorrhoea originates there, or elsewhere in the WHO Western Pacific Region 2 .
Whole-genome sequencing has been successfully used to reveal the origins, global spread and population structure of several human pathogens 15 . However, gonococcal genome sequencing has mostly targeted specific populations and outbreaks [16] [17] [18] [19] [20] . Here, we report the findings of a global genomic study of 419 N. gonorrhoeae isolates spanning 5 continents and more than 50 years, including varying susceptibilities to important antimicrobials. Our aim was to elucidate when and where modern gonococcal populations emerged, evolved and dispersed, and how antimicrobial usage and transmission in different sexual networks has influenced their population dynamics.
Results
Modern gonococcus is not 'as old as mankind' . Our collection spans a period of more than 50 years (1960-2013) and 58 countries from 5 continents ( Fig. 1 and Supplementary Table 1) . A population-level analysis revealed a high level of admixture among N. gonorrhoeae with no significant differentiation between continents ( Supplementary Table 2 ), with the exception of Africa ( Supplementary Fig. 1 and Supplementary Tables 3-5 ). We estimated the substitution rate for the non-recombining section of the genomes in the collection ( Supplementary Fig. 2 ) to be 3.74 × 10 −6 substitutions per site per year confidence interval (CI; 3.39 × 10 −6 to 4.07 × 10 −6 ), which is similar to previous reports 16, 18 and comparable to other bacteria 21 . The time of the most recent common ancestor (tMRCA) was estimated to be around the sixteenth century (1589, CI: 1544-1623) ( Fig. 2 ). Although high rates of recombination can lead to underestimation of tMRCAs to some extent, these results are strongly at odds with the hypothesis that modern gonorrhoea has existed as long as mankind and cast further doubt on the ascribing of historical descriptions of gonorrhoea-like symptoms to infection with 'modern' gonococci.
Despite modern gonococci being globally mixed, we found strong evidence of historic geographical separation, suggesting that rapid mixing of populations is a relatively recent phenomenon. A phylogeographical analysis ascribed the origin of our collection to Europe (60.9% inferred ancestry). However, when corrected for biases in the number of samples from each continent, complementing with isolates from a US study 16 , there was support for an African origin (90.7% inferred ancestry) ( Supplementary Fig. 3 and Supplementary Table 6 ). From this African root, we identified numerous change points in the continental distribution of isolates across the tree ( Supplementary Fig. 3 ). Most of these were recent events, but the most significant change point separated a basal lineage containing a high proportion of African isolates (68.2%, 30 out of 44) from a lineage containing a high proportion of Asian isolates (92.6%, 137 out of 148), despite the temporal sampling from the two continents being similar ( Supplementary Fig. 3 ). When combined with the dating, this can be interpreted as an early introduction of the modern gonococcus population into Asia (1617, CI: 1578-1649; Fig. 2 ) soon after its emergence. More recently, many re-introductions into the rest of the world have occurred from this Asian lineage, contributing to the highly mixed population observed today. Fig. 4 ) and the occurrence of genetic AMR determinants were significantly higher among the isolates belonging to the lineage that arose after the phylogeographical breakpoint representing the initial introduction into Asia (Wilcoxon test W = 66,159, P < 0.0001) (Figs. 3 and 4c). Thus, we refer to the 298 isolates after the breakpoint as lineage A and the 121 isolates before the breakpoint as lineage B.
Emergence of antimicrobial-resistant gonorrhoea. Minimum inhibitory concentrations (MICs) for six antimicrobials (Supplementary
Two AMR determinants, folP R228S, which reduces susceptibility to sulfonamides, and rpsJ V57M, which reduces susceptibility to tetracyclines, were carried by a large proportion of isolates, especially in lineage A ( Fig. 3 and Supplementary Table 1 ). Fifty-one isolates contained a mosaic penA allele 22 . We identified three independent gains of mosaic alleles, all in lineage A. In a clade of 59 isolates with multilocus sequence typing (MLST) ST1901, a first recombination event replaced the wild-type allele with a mosaic penA10 allele and a subsequent event replaced penA10 with mosaic penA34. These two alleles differ by 16 single-nucleotide polymorphisms (SNPs) and a codon insertion in the last 105 bases of the nucleotide sequence. Two isolates in this clade exhibited high MICs for both cefixime (3-4 mg l −1 ) and ceftriaxone (2 mg l −1 ) ( Supplementary Fig. 5 ), and these were found to possess penA42, which is a single SNP (A501P) variant from penA34 (refs. 23, 24 ). In another lineage, associated with MLST ST7363, most isolates possessed the penA10 alleles, but we again observed a case of replacement with penA34. Only one isolate carried the A2045G 23S rRNA mutation (A2059G in Escherichia coli) that confers high-level resistance to azithromycin. Six isolates carried the low-level azithromycin resistance C2597T 23S rRNA mutation (C2611T in E. coli). Strikingly, the plasmids carrying tetM and bla TEM colocalized far more frequently than expected (Pearson's χ 2 = 97.82, d.f. = 1, P < 0.0001), possibly reflecting the mobilization of pBlaTEM by the pConjugative plasmid 25 , and were completely absent from isolates resistant to extended-spectrum cephalosporins (ESCs) (Fig. 3 ). The gonococcal genomic island was found in 277 (67%) isolates ( Supplementary Fig. 6 ), but showed no clear association with AMR. The plasmid-encoded resistances showed no significant difference in prevalence in lineage A or lineage B (two-sided test for equality of proportions for tetM: χ 2 = 0.01, 95% CI: −0.089 to 0.110, d.f. = 1, P = 0.92, and for bla TEM : χ 2 = 0.88, 95% CI: −0.046 to 0.147, d.f. = 1, P = 0.35). By contrast, of the 29 chromosomally mediated resistance substitutions examined, 18 were significantly associated with clade A (Fig. 3 ). Importantly, based on our phylogenetic dating, the majority of occurrences of these 29 determinants were estimated to have been acquired after the introduction of the antimicrobial against which they act ( Supplementary Fig. 7 ). Two strategies for gonococcal success. Overall, our data show far fewer gains of chromosomally encoded AMR determinants in lineage B than in lineage A ( Supplementary Fig. 8 ). As these determinants primarily spread through the population via homologous recombination, such differences could be explained by differences in recombination frequency. To assess this, we compared the proportion of homoplasic sites, an indicator of recombination, in the terminal branches of the phylogenetic tree in the two lineages. This confirmed a significantly higher proportion in clade A, particularly for short branches, which represent very recent evolution (Wilcoxon test W = 19,416, P < 0.001; Fig. 4a,b and Supplementary  Fig. 9 ). Note that the distribution of branch lengths in both clades was similar (Wilcoxon test W = 14,427, P = 0.739). Similarly, the proportion of clustered SNPs, another sign of recombination, was also higher on the terminal branches in lineage A (Wilcoxon test W = 16,984, P < 0.05). The proportion of recombination-deficient strains (those with no recombination events detected, r = 0) in lineage B was higher than expected, bordering on statistical significance (one-tailed test of proportions, P = 0.05184).
One explanation for such differences could be opportunity. For recombination to occur, donor and recipient bacteria must colocalize. Thus, recombination between gonococci would be expected to occur more frequently in high-risk host populations where co-infection with other STIs and pharyngeal infections, which allow access to commensal Neisseria species, are more common. These risk groups are also more likely to be exposed to repeated antimicrobial therapy for gonorrhoea infection and other STIs 5 . Unfortunately, due to limitations in the availability of data on patient sexual behaviour, we could not adequately assess the association of the lineages to risk factors in our data set. However, we could analyse the distribution of the gender of the patients from whom the isolates were taken. To increase the power of the analysis, we included 376 isolates from two North American genomic studies 17, 26 , to give a set of 639 isolates with complete gender information. Strikingly, lineage B included a significantly higher proportion of women (40 out of 136, 29.4%) than lineage A (69 out of 503, 13.7%) (two-sided test for equality of proportions χ 2 = 17.54, 95% CI: 0.070-0.244, d.f. = 1, P < 0.0001) ( Fig. 4d and Supplementary Fig. 8 ), which would suggest that lineage B is more closely associated with heterosexuals. Corroborating this, data from a 2013 European-wide structured survey 27 showed a similar pattern. Lineage B isolates were strongly associated with reduced MICs and female patients (61 out of 214, 28.5% of lineage B isolates were from women versus 100 out of 821, 12% of lineage A; two-sided test for equality of proportions χ 2 = 33.21, 95% CI: 0.096-0.231, d.f. = 1, P < 0.0001), and more importantly, of the patients that reported sexual orientation, 78.3% (94 out of 120) of isolates in lineage B were from heterosexuals, in contrast to 52.6% (200 out of 380) in lineage A (two-sided test for equality of proportions χ 2 = 23.82, 95% CI: 0.162-0.352, d.f. = 1, P < 0.0001) ( Supplementary Fig. 10 ). Particular sublineages within lineage B appeared to be particularly strongly associated with heterosexuals 27 . We suspect that lineage A, being associated with higher-risk populations, does have greater opportunity for recombination, which may explain the observed higher recombination rate. However, transmission between low-risk and high-risk populations is common within lineage A, so we suspect that opportunity is not the only explanation for the differential recombination rate in the two lineages. The observation that plasmid-born resistances do not show the same difference in frequency between the two lineages also supports this view.
Discussion
Gonorrhoea is one of the most clinically important STIs worldwide. Its rapid mode of transmission, especially among high-risk groups, and the emergence of resistance to many antimicrobials, has made the control of N. gonorrhoeae of primary importance for public health. In recent years, there has been an understandable focus on AMR gonorrhoea, with resistance to all classes of antimicrobials used to treat the infection having been reported 2 . However, the increase in prevalence of gonorrhoea has continued in many settings 6 despite resistance to dual therapy being extremely rare. Our genomic analysis revealed a contemporary global population with little geographical structure, suggesting that rapid recent intercontinental transmission is occurring. In particular, introductions from Asia into the rest of the world appear common, consistent with the observation that a number of recent resistant gonococcal clones have emerged from this region 2 . The one exception was Africa, where the sampled gonococcus was less diverse. The dated maximum likelihood phylogenetic tree shows the posterior probabilities for each continent at every node (pie charts). Continents of isolation (prior) are shown as metadata next to the tips (n = 419). The top left graph contains information on the proportion of strains from different continents before (n = 121) and after (n = 298) the introduction to Asia.
However, our African sample size was small due to the limited availability of isolates, so further study is required in this area. We estimated an origin of modern gonococci in the sixteenth century (1544-1623), which contrasts with historical interpretations of modern gonorrhoea as an ancient disease. Although we are keen to stress that high rates of recombination make accurate estimates difficult and that our estimated CIs are probably too narrow, this dating suggests that ancient accounts of gonorrhoeal-like symptoms may have been caused by other pathogens or are evidence of an ancient N. gonorrhoeae population distinct from that observed today. It certainly disputes the view that the disease that we now know as gonorrhoea is 'as old as mankind' . The sixteenth century was, nonetheless, an opportune time for the global dissemination of pathogens. It was a period of early modern globalization marked by the initiation and intensification of many intercontinental trade links, particularly by sea 28 . This period was of utmost importance for globalization due to an expeditious increase in exchange of goods, including the import of crops from the Americas to Europe. Increased movement of people around the world also spawned local epidemics and pandemics 29 , and may well have played an important role in the evolution of modern gonorrhoea. A phylogeographical analysis using several subsampled sets of strains from different continents to avoid bias placed the origin of the current global gonococcal population in Europe or Africa. We identified a subsequent introduction into Asia in the early seventeenth century (1578-1649), which expanded rapidly throughout the continent. Much more recently, this lineage has been repeatedly transmitted back to the rest of the world.
A major finding is a strong association between isolates from the lineage that evolved from this early introduction to Asia and the development of AMR. Nearly all isolates in this lineage A, but only 50% of those in lineage B, harboured resistance to sulfonamides (folP R228S mutation) and tetracyclines (rpsJ V57M mutation). Sulfonamides were the first antimicrobials introduced to treat gonorrhoea in 1935, with initial efficacies of around 90%. By the mid-to-late 1940s sulfonamide resistance was common and it was discarded as a treatment for gonorrhoea 2 . However, sulfonamides are still widely used in combination with trimethoprim for prophylaxis in patients who are HIV positive and to treat various bacterial infections 30 . Doxycycline (a tetracycline) is still used to treat gonococcal or presumptively non-gonococcal urethritis/cervicitis and is the recommended treatment for lymphogranuloma venereum 31 . Thus, we suspect that the high incidence of sulfonamide and tetracycline resistance in modern gonorrhoea is due to historic treatment of the disease itself followed by continued use of these drug classes for other purposes. The high proportion of diverse circulating strains carrying the folP and rspJ mutations could be used as evidence that they were in the gonococcal population long before the introduction of antimicrobials. However, this seems unlikely. More plausibly, the use of sulfonamides and tetracyclines has produced a strong selective pressure over an extended period of time, which has led to many independent acquisitions of resistance mutations and convergent gains of resistance via homologous recombination. In the more recombinogenic lineage A, this has resulted in these mutations sweeping through the entire clade. Furthermore, other AMR determinants that have entered the gonococcal population more recently appear to be undergoing the same process, particularly in lineage A. The DNA gyrase A S91F substitution, which provides resistance to ciprofloxacin, is one of many resistance mutations that show extremely high levels of homoplasy in lineage A, consistent with a combination of de novo mutation and rapid dissemination via recombination. The mosaic penA alleles, which reduce susceptibility to extended-spectrum cephalosporins are another example. These elements were first described in N. gonorrhoeae around the turn of the century, but have already been independently acquired by numerous A sublineages, clearly showing that these mutations are transferring en masse via recombination rather than by repeated de novo mutation. Conversely, lineage B has remained susceptible to most antimicrobials. More generally, the levels of homoplasy and SNP clustering were found to be significantly higher in clade A, supporting the hypothesis that higher rates of recombination in this lineage have played a role in its high levels of AMR. The rise of AMR gonorrhoea is generally assumed to have been facilitated by particular demographics who partake in high-risk sexual behaviours, particularly unprotected sex with multiple partners. These groups are also more often treated with antimicrobials than the general population due to frequent infection 32 . Concordantly, we found that lineage A is associated with infection in men who have sex with men, one of the predominant risk groups, whereas isolates from lineage B are more rarely found in this demographic group. Thus, lineage A isolates have the means (increased homologous recombination), motive (higher antimicrobial exposure) and opportunity (higher rates of co-infection with commensal Neisseria and other STIs) for recombination-driven gain of AMR.
Most recent media attention and gonococcal genomics research has focused on the increasing levels of AMR in gonorrhoea. However, we have shown that a mostly susceptible lineage is successfully persisting in lower-risk groups where it is probably less likely to be exposed to antimicrobials. Notably, this lineage was associated with heterosexual groups and with infections in women, where rates of asymptomatic infection are higher. Turner et al. 33 showed, using a modelling approach, that in a situation where both resistant and susceptible strains are present in a population, high rates of asymptomatic infection, and therefore undertreatment, can allow susceptible isolates to survive and thrive. In such circumstances, rates of susceptible infection can be hugely underestimated, potentially meaning that our understanding of gonococcal prevalence and rates of AMR may be biased. Interestingly, the majority of our African samples were from lineage B, consistent with epidemiological studies that describe a hidden epidemic of gonococcus in rural South African women, in which 48% of cases were asymptomatic and another 50% were symptomatic but not seeking care 34 . Similarly, in Namibia, the prevalence of asymptomatic gonococcal infections in both men and women in rural villages is high 35 .
This may suggest that lineage B is associated with asymptomatic infection more fundamentally than simply being more often found in women. In such a situation, if compensatory mutations are not developed, gain of AMR determinants may be detrimental as these elements may come with an associated general cost to fitness. Grad et al. 36 reported, for example, that 23S rRNA mutations resulting in azithromycin resistance were associated with reduced ESC MICs in isolates with mosaic penA alleles. Similarly, we have observed that the tetM and bla TEM -containing plasmids are negatively associated with isolates with mosaic penA alleles.
In conclusion, in the first phylogeographical analysis of a global collection of gonococci, we have shown that, although the modern gonococcal population is highly mixed, this mixing is relatively recent. This gonococcal population originated as late as the sixteenth century, most likely in Europe or Africa, and an early single introduction into Asia led to a rapid spread throughout the continent and the rest of the world. Despite most recent focus being on gonococcal AMR, we have demonstrated that N. gonorrhoeae has adapted to sexual networks with different risk profiles and exposures to antimicrobial treatment. Modern global gonorrhoea can be divided into two lineages, which we term lineage A (after the phylogenetic breakpoint) and lineage B (before the phylogenetic breakpoint). Lineage A has gained and proliferated AMR determinants, aided by an increased rate of recombination. We hypothesize that these isolates are often transmitted in higher-risk networks, for example, men who have sex with men, where pharyngeal infections are more common and individuals are more frequently exposed to treatment for gonorrhoea and other STIs. However, lineage B has not gained AMR so rapidly, with 26% of isolates containing no known AMR determinants, and is potentially being silently transmitted in undertreated groups where levels of asymptomatic infection are higher. Thus, our results have shown that the effect of antimicrobial treatment on the gonococcal population has been more complex than simply initiating an inexorable progression towards AMR.
Methods
Global N. gonorrhoeae strains and antimicrobial susceptibility testing. A total of 413 N. gonorrhoeae strains without known epidemiological relatedness were collected from patients with gonorrhoea in 58 countries spanning 5 continents. The strains were selected to represent a wide geographical, temporal, phenotypic (based on AMR) and genetic diversity, that is, to represent as much as feasible of the N. gonorrhoeae species phylogeny ( Supplementary Table 1 ). Six genome references were also included in the study, spanning a range of isolation dates between 1960 and 2013 in total. Bacterial isolation from the corresponding samples, preservation and transportation was performed following standard microbiological procedures 37 . β-Lactamase production and MICs were tested for a range of antimicrobials as described previously 38 : spectinomycin, tetracycline, penicillin G, ciprofloxacin, azithromycin, cefixime and ceftriaxone.
DNA preparation and whole-genome sequencing. All isolates were confirmed to be N. gonorrhoeae and genomic DNA was extracted from the isolates using the Promega Wizard DNA purification kit, following the instructions from the manufacturer. Purified DNAs were multiplexed and sequenced using two lanes of the HiSeq 2500 2 × 100 bp platform at the Wellcome Sanger Institute (Hinxton, UK).
Mapping and variant calling. Fastq files from the 413 new gonococcal strains and the Neisseria meningitidis 10356_1#65 outgroup (ENA accession number: ERS248641) were mapped to a common reference, N. gonorrhoeae FA1090 (NCBI accession NC_002946; 2,153,922 bp) using SMALT v0.7.4 (http://www.sanger. ac.uk/science/tools/smalt-0). Variants were called using SAMtools and BCFtools v1.2 (ref. 39 ) after indel (insertion or deletion) realignment with GATK v1.5.9 (ref. 40 ) and further filtered as described previously 41 .
Six public reference genomes were obtained from the NCBI and aligned using progressiveMAUVE v2.3.1 (ref. 42 ) (N. gonorrhoeae FA1090 (NCBI accession NC_002946.2), FA19 (NCBI accession CP012026.1), FA6140 (NCBI accession CP012027.1), MS11 (NCBI accession NC_022240.1), 35/02 (NCBI accession CP012028.1) and NCCP11945 (NCBI accession NC_011035.1)). The XMFA output alignment was converted into a plain fasta format using N. gonorrhoeae FA1090 as a reordering reference through a custom Perl script (see 'Code availability'). Positions with gaps in this reference were removed, so that the resulting alignment had homologous positions to the 2,153,922 bp in the FA1090 genome. This alignment was added into the alignment resulting from mapping the 413 isolates, producing a 419-strain alignment containing the core genome and accessory sites from FA1090 that are shared by any other strain in the collection.
Recombination removal and phylogenetic reconstruction. Prophages described in the N. gonorrhoeae FA1090 strain 43 were masked in the alignment before running Gubbins v1.4.10 (ref. 44 ), which was used to remove segments that can have undergone recombination. This is done by detecting regions of the alignment in which SNPs are densely clustered and occur on the same branches of the tree. The N. meningitidis 10356_1#65 strain was used as the outgroup so that events affecting all N. gonorrhoeae strains were not excluded from subsequent calculations.
The detected recombination events and repeat regions inferred by repeatmatch (MUMMER v3.23) 45 using default options on the N. gonorrhoeae FA1090 strain genome were masked to minimize the occurrence of false-positive SNPs. Gblocks v0.91b 46 was run on the resulting alignment to further clean poorly aligned regions that may introduce noise to phylogenetic analyses. Gblocks was run by allowing gap positions in up to 50% of the sequences, with a minimum block length of 10 and 8 as the maximum number of contiguous non-conserved positions. The resulting 1,211,180-bp clean alignment included 15,562 variable sites, identified by snp-sites 47 , and was used for population structure analysis, phylogenetic inference and divergence estimation. Genetic clusters were obtained from the non-recombining alignment using hierBAPS v7.3 (ref. 48 ).
The final SNP alignment was used for maximum likelihood phylogenetic tree reconstruction using RAxML v7.8.6 (ref. 49 ) under the GTRGAMMA model of nucleotide substitution and 100 bootstrap replicates. An algorithm called BOOSTER v0.1.2 (ref. 50 ) was also used to obtain an enhanced estimate of node support values (Supplementary Note). Ancestral states of all SNPs before recombination removal were reconstructed onto the resulting phylogenetic tree using ACCTRAN transformation in python (http://scikit-learn.org). Homoplasic sites in the terminal branches of the tree were detected for the whole tree and the two main lineages. It is important to note that Gubbins removed 97% (33,026 out of 34,034) of those homoplasic sites, minimizing their effect on subsequent analyses.
Genome de novo assembly and in silico typing. In parallel to the mapping process, reads were assembled using the assembly and improvement iterative pipeline developed at the Wellcome Sanger Institute 51 . MLST 52 and N. gonorrhoeae multi-antigen sequence typing (NG-MAST) 53 typing schemes were retrieved directly from the sequences using the get_sequence_type script (https://github. com/sanger-pathogens/mlst_check/blob/master/bin/get_sequence_type) and NGMASTER v0.4 (ref. 54 ), respectively. The presence of the β-lactamase (bla TEM ) and tetracycline (tetM) genes on plasmids and the gonococcal genomic island were detected using BLAST v2.3.0+ 55 and ARIBA v2.4 (ref. 56 ). Typing was performed for the conjugative plasmid and the bla TEM plasmids using an in silico PCR (https:// github.com/simonrharris/in_silico_pcr). Primers to differentiate between the Dutch and the American tetM-containing plasmids were obtained from Turner et al. 57 . To type the bla TEM plasmids, the primers described in Dillon et al. 58 were used and the resulting amplicon sizes were evaluated to differentiate among the Asia, Africa and Toronto/Rio types (Supplementary Table 1 ).
Analysis of population structure.
To study population structure from the resulting alignment, the poppr R package v2.5.0 (ref. 59 ) was used to perform an analysis of molecular variance (AMOVA) test on the non-recombining section of the genome 60 on three geographical hierarchies-continent, subcontinent and country-to calculate the percentage of observed variance within and between groups. To test whether the observed differentiation between continents was significant, a randomization test (n = 1,000 permutations) was performed using the randtest function from the ade4 R package v1.7-11 (ref. 61 ), which randomly permutes the population structure to assess the observed signal of differentiation.
To further study population structure, a discriminant analysis of principal components (DAPC; adegenet R package v2.1.1) 62,63 analysis was applied to the non-recombining 15,562 SNPs alignment using continent of isolation as population. The procedure followed by this multivariate discriminant analysis tries to maximize the discrimination between the predefined groups. To avoid overfitting and to keep enough discrimination power, the optimal number of principal components to retain was determined using the a-score optimization test, which uses randomized groups to calculate the proportion of successful reassignments corrected by the number of retained principal components. This methodology resulted in 83 principal components as optimal to keep a balance between discrimination power and overfitting. Prior assignment to continents was randomized and the DAPC analysis was repeated to confirm that the observed separation among clusters does not occur by chance. Four discriminant functions were kept for the analysis, considering that the number of variables was five continents. A multivariate analysis of variance (MANOVA) test 64 was applied to test whether there were differences between the means of the different clusters (continents) on the discriminant clustering. Wilks' lambda was used to test the significance of this MANOVA test. Resulting P values were adjusted for multiple tests using the false discovery rate 65 .
DAPC derives group membership probabilities from the retained discriminant functions. These results were used to evaluate the level of admixture in the data set under study. Isolates assigned with >80% posterior probability to a continent different from the prior assignment were interpreted as intercontinental transmission cases. Isolates with <80% of posterior assignment to any of the continents were considered as admixed.
Divergence estimation with LSD and BEAST. The year of isolation for all of the strains was used to calculate a root-to-tip distance regression versus the time to make an estimate of the temporal signal in the data. To do this, a 'clustered permutation' approach was used as described 66, 67 , which considers potential confounding temporal and genetic structure in the data. A total of 1,000 permutations were performed with this method by randomizing the isolation dates to get an estimate of the statistical significance of the results. This procedure was applied to the whole data set and to the different BAPS clusters.
To get an estimate of the substitution rate and tMRCA for the whole N. gonorrhoeae global collection, the least-square dating (LSD) v0.3 software 68 was used. This approach has been shown to be robust to uncorrelated changes of the molecular clock and to give similar results to BEAST 68 . To compare the performance between LSD and BEAST, individual BAPS clusters were used. Specifically, Bayesian approximation using BEAST v1.8.2 (ref. 69 ) was run to estimate tMRCA and the substitution rate of the genetic clusters determined by hierBAPS 48 . Three chains were run per cluster up to 100 million generations by using a GTRGAMMA model of nucleotide substitution with 4 categories, strict molecular clock with a diffuse gamma distribution (shape 0.001 and scale 1,000) and a constant population size as priors. Default priors were used. For models using relaxed clocks, the ucld mean prior was set to a gamma distribution with shape 0.001 and scale 1,000. The same configuration was used to run two different chains with the whole collection, which did not reach proper convergence because of the complexity of the data set. LSD was also run for the BAPS clusters that reached convergence in BEAST and the results were compared (Supplementary Note). The obtained tMRCA was further confirmed using the Wald statistic (Supplementary Note).
Phylogeography with stochastic character mapping. The continent of isolation was used as a discrete trait to study changes in the distribution over the phylogenetic tree using treeBreaker v1.1 (ref. 70 ) (https://github.com/ansariazim/ treeBreaker). This program calculates the per-branch posterior probability of having a change in the distribution of a discrete character.
Stochastic character mapping 71 with a symmetric transition model (SYM) was applied to the phylogenetic tree to get posterior probabilities for each continent at every node using the make.simmap function implemented in the phytools R package v0. 6-44 (ref. 72 ). Given a phylogeny and a set of tip states ('continent' in this study), this method uses an MCMC approach to sample character histories from their posterior probability distribution consistent with those states given a model of evolution for the mapped character 73 . This procedure was applied to the prior and posterior continent assignments excluding the admixed individuals to reduce noise from the prior metadata.
An extra set of 236 isolates from the United States 16 was added to the global collection and the phylogeographical analyses were repeated to confirm our results. To avoid biases due to a different number of strains from different continents, the combined data sets were downsampled 100 times to n = 41 (the maximum number of strains with a posterior assignment to the continent with the least number of strains, Africa), except for Oceania, from which there are not more data in the public databases to include, generating 100 subtrees. Ten stochastic maps were inferred for each of those subtrees and posteriorly combined using phytools 72 , resulting in a total of 1,000 evaluated maps.
Evolution of AMR determinants. Mutations conferring AMR in known genetic determinants (16S rRNA, 23S rRNA, rpoB, rpsJ, mtrR, folP, gyrA, parC, parE, penA, ponA and porB) as well as the presence of the β-lactamase (bla TEM ) and tetM genes 74 were obtained for the 413 strains sequenced in this study using ARIBA v2.4 (ref. 56 ) ( Supplementary Table 1 ) with a custom database created for N. gonorrhoeae (precomputed version available in https://github.com/martinghunt/aribapublication/tree/master/N_gonorrhoeae/Ref). ARIBA searches for the presence of particular AMR genes and associated known mutations using reference sequences as a subject database and the fastq files of the strains in the collection as queries.
Subsequent analyses were performed using R v3.1.2 (ref. 75 ): the occurrence of different AMR determinants before and after the change point detected by treeBreaker on the distribution of continents and the distribution of MIC values for penicillin G, tetracycline, ciprofloxacin, ceftriaxone, cefixime and azithromycin against different combinations of the genetic determinants. The average number of changes from a susceptible to a resistant state was inferred for each of the resistant determinants under study in both lineage A and lineage B independently using stochastic mapping (100 simulations) with the make.simmap function implemented in the phytools R package 72 . The inferred number was corrected by the number of edges in each lineage: n = 586 in lineage A and n = 236 in lineage B.
As an approximation of studying the risk groups characterizing the defined A and B lineages, 263 isolates from the global collection with information on the gender of the patient were combined with 376 isolates from two North American studies with this information available 17, 26 . ARIBA v2.4 was run for the extra isolates and the obtained results were joined with the results from the global data set. Metadata on gender and the number of total resistance determinants detected per strain was plotted on a recombination-free phylogenetic tree obtained as described above and differences between the two lineages were evaluated using two-sided tests for equality of proportions with continuity correction (prop.test) and two-sided Wilcoxon rank sum tests (wilcox.test) with R 75 .
To confirm our hypothesis on the two lineages being associated to different risk groups and antimicrobial susceptibilities, we downloaded the phylogenetic tree of 1,054 European isolates from a 2013 Euro-GASP survey from the Pathogenwatch N. gonorrhoeae scheme 27 (https://pathogen.watch/collection/eurogasp2013). The breakpoint between lineage A and lineage B was detected by obtaining a combined core genome alignment of this and our global set (1,473 strains in total) using Roary v3.11.3 (ref. 76 ) and running a pseudo-maximum likelihood tree with the resulting SNPs 47 with FastTree v2.1.9 (ref. 77 ).
Visualization. Visualization of metadata in phylogenetic trees was performed using iTOL v4 (ref. 78 ). Mapping and the presence or absence of AMR determinants detected with ARIBA were visualized using Phandango v1.1.0 (ref. 79 ).
Reporting Summary. Further information on research design is available in the Nature Research Reporting Summary linked to this article.
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